% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

saltheartrules 5 posts  |  Last Activity: Apr 6, 2015 10:40 PM Member since: Jun 28, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    "better equipped to sell our therapy"

    by haoliepastor Apr 6, 2015 10:04 PM
    saltheartrules saltheartrules Apr 6, 2015 10:40 PM Flag

    My nephew is a regional sales manager for a medical device company and he has a hard time getting qualified salesman. When he does get one he treats him like gold cause he knows how valuable they can be.. It takes a certain personality to sell directly to doctors and I'm glad Chan is being picky...

  • saltheartrules saltheartrules Apr 4, 2015 6:01 PM Flag

    The filter removes an array of pro and antiinflammatory cytokines...
    There is a definite corrolation between elevated cytokines and negative outcomes..
    The Renal research dept. at Fresenius(heavy hitters in the medical community) have formulated a theory of treatment called the "Peak Concentration Hypothesis" to treat severe sepsis patients..
    This theory states the most logical approach to treating sepsis is removing as many of the pro and antiinflammatory cytokines thereby avoiding the all encompassing peak concentrations of cytokines which lead to septic storm and ultimately death...
    I have confidence that this theory is correct and Cytosorbents will prevail in conquering this indication..
    I also think the first step involves proving the filters efficacy in treating inflammation, the first step in sepsis.. Cardiac surgery is the convenient idiot in this journey..
    Chan feels he can whip through a considerably less expensive trial treating these patients to prove the filters efficacy plain and simple..

  • Reply to

    Vienna is on my mind.

    by shortsaretoast Apr 4, 2015 2:57 PM
    saltheartrules saltheartrules Apr 4, 2015 5:19 PM Flag

    I think if there were glowing results they would have rolled out the data by now..
    I think we'll get more along the lines of the german trial where there is a lot of post hoc data that paints a picture of an opaque efficacy... This is the first data for this patient profile after all
    I think the trial was seen as an overall success though as Chan has gone after this cardiac indication in the US after having known the results in Vienna for some time..
    I've been here for 5 years and am out now but have been waiting for a dip like this to buy back in..
    I think a cardiac trial success in the US will lead to on label uptake at decreasing inflammation in the ICU all around the world........

  • saltheartrules saltheartrules Mar 27, 2015 4:08 PM Flag

    As I recall one of the main reasons cytorsorb went the route of treating critical care is that there were higher returns than dialysis treatments....

  • saltheartrules saltheartrules Feb 22, 2015 1:56 PM Flag

    I beieve you're right in that they have potential to grow into a powerhouse in the solar sector. Great flashy products that are just starting to take off in popularity...

7.52+0.5000(+7.12%)Apr 24 4:00 PMEDT